Mark S. Blumenkranz - 15 Jul 2021 Form 4 Insider Report for IVERIC bio, Inc.

Role
Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz
Issuer symbol
N/A
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
4
Filing time
19 Jul 2021, 16:13:56 UTC
Previous filing
07 Jun 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +5,000 5,000 15 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -5,000 -33% $0.000000 10,000 15 Jul 2021 Common Stock 5,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 On July 15, 2020, the Reporting Person was granted 15,000 restricted stock units, which vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date, subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.